LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS
Clinical trials for LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS explained in plain language.
Never miss a new study
Get alerted when new LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS trials appear
Sign up with your email to follow new studies for LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could LVAD patients ditch aspirin? new trial aims to find out
Disease control Not yet recruitingThis study tests whether patients with a heart pump (LVAD) can safely stop taking aspirin while continuing warfarin. The goal is to reduce bleeding problems without increasing dangerous clots. About 370 participants will be randomly assigned to receive either aspirin or a placebo…
Matched conditions: LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Could a common blood thinner replace warfarin for LVAD patients?
Disease control Not yet recruitingThis study compares two blood thinners—apixaban (Eliquis) and warfarin (Coumadin)—in 460 people with advanced heart failure who have a HeartMate 3 heart pump. The goal is to see which drug better prevents strokes, pump clots, and serious bleeding. Participants must have had their…
Matched conditions: LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS
Phase: PHASE3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC